Biocrates - Metanomics Health have merged to create the Total Solution Provider - Metabolomics. The broadest technology portfolio in the market - covering untargeted as well as targeted approaches, kit and service offerings - is complemented with a strong expertise in data interpretation.
The combined solutions have been well perceived. We are thankful for the trust and support from our clients and partners.
To further increase awareness for the new possibilities, Biocrates and Metanomics Health support a series of upcoming events. We are looking forward to meeting you at:
- Webinar "Metabolomics in drug development and precision medicine", May 23, 2018 - ASMS 2018, San Diego, June 3-8, 2018 - Metabolomics 2018, Seattle, June 23-28, 2018 - Local Metabolomics symposia: Milano, May 23, 2018 and Erlangen, June 20, 2018
For details about either of the events please see below.
- NEW: Global Metabolic Profiling - Hundreds of Metabolites Quantified, Sample Quality Assessment Included
Webinar "Metabolomics in drug development and precision medicine" May 23, 2018
Speaker:Dr. Tim Bölke Biocrates Chief Medical Officer, Metanomics Health General Manager
ASMS 2018 June 3-8, 2018 San Diego, CA
Meet and discuss with us at: - Breakfast Seminar, Tuesday, June 5, 2018, at 07:00 am, room 10 Speaker: Jerzy Adamski, Helmholtz Zentrum Munich. The Benefit of Working with a Standardized Metabolomics Platform: The Relevance of Comprehensive Steroid Profiling in Human Population Cohort Studies - Thermo Fisher ScientificTM User Meeting, Sunday, June 3, 2018 Speaker: Will Thompson, Duke University Results from an international ring trial with the AbsoluteIDQ® p400 HR Kit - Booth #620
Annual Meeting Metabolomics Society 2018 June 24-28, 2018 Seattle, WA
Meet and discuss with us at: - Booth #112 - Short Presentation, June 27, 2018 at 3:30 p.m.
Local Metabolomics Symposia
May 23, 2018 IRCCS-Istituto Mario Negri, Via la Masa 19, Milano, Italy
3rd MetaboMI Meeting Lipidomics in Metabolism and Diseases: Challenges in Technologies and Applications
June 20, 2018 Kinder- und Jugendklinik, Universitätsklinikum Erlangen
Pädiatrischer Nachmittag Metabolische Signaturen: Multiparameteranalytik in der medizinischen Diagnostik und Forschung
Biocrates and Metanomics Health have recently merged to create a new global leader in Metabolomics and early disease detection. As a total solution provider, Biocrates and Metanomics Health provide the broadest technology and product portfolio in the industry. The merged companies have extensive expertise in targeted and global metabolic profiling, customized assay development, targeted screening kits, and data interpretation. Finally, capabilities in CDx / Diagnostic Kit development make Biocrates and Metanomics Health the preferred partner for all your requirements in metabolite analysis.
Biocrates’ metabolomics kits allow for the analysis of up to 400 metabolites across multiple analyte classes in a single run. The whole range of analytical and data interpretation services is available through the company’s service laboratories in Berlin, Germany and Innsbruck, Austria.
Biocrates products related to this email are for research use only. Not for use in diagnostic procedures.
BIOCRATES Life Sciences AG Eduard-Bodem-Gasse 8 6020 Innsbruck AUSTRIA
If you no longer wish to receive information from BIOCRATES Life Sciences AG by email, please click here to unsubscribe. This email was sent by: BIOCRATES Life Sciences AG, Eduard-Bodem-Gasse 8, 6020 Innsbruck firstname.lastname@example.org Phone +43.512.579 823, Fax +43.512.579 823–329, FN 220414 p LG Innsbruck, UID No.: ATU 56725128